Illustrative image – not actual.Cadila Pharmaceuticals (CPL) is exploring the possibilities of setting up a manufacturing unit in war-ravaged Afghanistan. An investment of Rs.10 crore is envisaged.
According to CPL chairman, I A Modi, a delegation of the company would shortly visit Kabul to assess the business environment in Afghanistan. A final decision on the project would be taken thereafter. Afghanistan is currently scouting for foreign investments in various industrial sectors.
The pharmaceuticals sector is almost non-existent and the country is totally dependent on import of medicines. With the interim government considering healthcare as a priority sector, Afghanistan offers excellent business potential to pharma companies intending to set up a base there.
The only major unit that was operational was that of Hoechst Pharmaceuticals which was shut down during the Taliban regime. Hoechst now plans to reopen this unit.
